Vitrolife AB (publ) (VTRLY)
USD 19.8
(0.0%)
USD 19.8
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.97 Billion SEK | -2.36% |
| 2022 | 1.78 Billion SEK | 70.16% |
| 2021 | 1.04 Billion SEK | 36.27% |
| 2020 | 767.66 Million SEK | -18.22% |
| 2019 | 938.65 Million SEK | 23.32% |
| 2018 | 761.12 Million SEK | 11.65% |
| 2017 | 681.7 Million SEK | 21.45% |
| 2016 | 561.3 Million SEK | 15.78% |
| 2015 | 484.82 Million SEK | 38.87% |
| 2014 | 349.11 Million SEK | 16.16% |
| 2013 | 300.55 Million SEK | 26.12% |
| 2012 | 238.3 Million SEK | 0.01% |
| 2011 | 238.27 Million SEK | 15.58% |
| 2010 | 206.15 Million SEK | 6.88% |
| 2009 | 192.88 Million SEK | 23.45% |
| 2008 | 156.25 Million SEK | 20.5% |
| 2007 | 129.66 Million SEK | 11.28% |
| 2006 | 116.52 Million SEK | 40.51% |
| 2005 | 82.92 Million SEK | 11.5% |
| 2004 | 74.37 Million SEK | 20.66% |
| 2003 | 61.63 Million SEK | 24.87% |
| 2002 | 49.36 Million SEK | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 499 Million SEK | 19.38% |
| 2024 Q1 | 418 Million SEK | -7.52% |
| 2024 Q3 | 508 Million SEK | 1.8% |
| 2023 Q2 | 505 Million SEK | 4.12% |
| 2023 Q4 | 452 Million SEK | -4.44% |
| 2023 FY | 1.73 Billion SEK | -2.36% |
| 2023 Q1 | 485 Million SEK | 4.75% |
| 2023 Q3 | 473 Million SEK | -6.34% |
| 2022 Q2 | 471 Million SEK | 12.41% |
| 2022 Q1 | 419 Million SEK | 39.93% |
| 2022 Q4 | 463 Million SEK | 8.43% |
| 2022 Q3 | 427 Million SEK | -9.34% |
| 2022 FY | 1.78 Billion SEK | 70.16% |
| 2021 Q3 | 262.56 Million SEK | 10.72% |
| 2021 Q4 | 299.42 Million SEK | 14.04% |
| 2021 Q1 | 246.95 Million SEK | -1.93% |
| 2021 Q2 | 237.14 Million SEK | -3.98% |
| 2021 FY | 1.04 Billion SEK | 36.27% |
| 2020 FY | 767.66 Million SEK | -18.22% |
| 2020 Q1 | 205.62 Million SEK | -18.56% |
| 2020 Q2 | 111.19 Million SEK | -45.92% |
| 2020 Q4 | 251.82 Million SEK | 26.53% |
| 2020 Q3 | 199.02 Million SEK | 78.99% |
| 2019 Q2 | 244.9 Million SEK | 23.75% |
| 2019 Q4 | 252.48 Million SEK | 3.76% |
| 2019 Q1 | 197.9 Million SEK | -7.7% |
| 2019 FY | 938.65 Million SEK | 23.32% |
| 2019 Q3 | 243.34 Million SEK | -0.64% |
| 2018 Q3 | 187.85 Million SEK | 0.28% |
| 2018 Q4 | 214.42 Million SEK | 14.14% |
| 2018 Q1 | 171.5 Million SEK | -1.41% |
| 2018 FY | 761.12 Million SEK | 11.65% |
| 2018 Q2 | 187.33 Million SEK | 9.23% |
| 2017 Q3 | 163.34 Million SEK | -12.47% |
| 2017 FY | 681.7 Million SEK | 21.45% |
| 2017 Q4 | 173.96 Million SEK | 6.5% |
| 2017 Q2 | 186.61 Million SEK | 18.26% |
| 2017 Q1 | 157.79 Million SEK | -6.34% |
| 2016 Q2 | 136.72 Million SEK | 9.23% |
| 2016 Q4 | 168.48 Million SEK | 28.69% |
| 2016 FY | 561.3 Million SEK | 15.78% |
| 2016 Q1 | 125.17 Million SEK | -8.57% |
| 2016 Q3 | 130.91 Million SEK | -4.25% |
| 2015 Q1 | 106.43 Million SEK | 17.91% |
| 2015 Q3 | 119.63 Million SEK | -1.81% |
| 2015 Q2 | 121.83 Million SEK | 14.47% |
| 2015 Q4 | 136.91 Million SEK | 14.44% |
| 2015 FY | 484.82 Million SEK | 38.87% |
| 2014 Q3 | 88.87 Million SEK | -0.19% |
| 2014 Q2 | 89.04 Million SEK | 10.04% |
| 2014 Q4 | 90.26 Million SEK | 1.56% |
| 2014 Q1 | 80.92 Million SEK | -2.92% |
| 2014 FY | 349.11 Million SEK | 16.16% |
| 2013 Q4 | 83.35 Million SEK | 15.06% |
| 2013 FY | 300.55 Million SEK | 26.12% |
| 2013 Q1 | 68.61 Million SEK | 8.12% |
| 2013 Q2 | 76.13 Million SEK | 10.96% |
| 2013 Q3 | 72.44 Million SEK | -4.85% |
| 2012 Q1 | 67.89 Million SEK | 5.54% |
| 2012 Q3 | 54.93 Million SEK | -12.78% |
| 2012 Q2 | 62.98 Million SEK | -7.23% |
| 2012 Q4 | 63.46 Million SEK | 15.51% |
| 2012 FY | 238.3 Million SEK | 0.01% |
| 2011 FY | 238.27 Million SEK | 15.58% |
| 2011 Q1 | 58.8 Million SEK | 7.46% |
| 2011 Q4 | 64.33 Million SEK | 11.48% |
| 2011 Q3 | 57.7 Million SEK | 0.48% |
| 2011 Q2 | 57.43 Million SEK | -2.33% |
| 2010 FY | 206.15 Million SEK | 6.88% |
| 2010 Q4 | 54.72 Million SEK | 14.83% |
| 2010 Q3 | 47.65 Million SEK | -8.32% |
| 2010 Q2 | 51.97 Million SEK | 0.35% |
| 2010 Q1 | 51.79 Million SEK | 9.85% |
| 2009 Q4 | 47.15 Million SEK | 1.42% |
| 2009 Q2 | 50.03 Million SEK | 0.0% |
| 2009 FY | 192.88 Million SEK | 23.45% |
| 2009 Q3 | 46.49 Million SEK | -7.08% |
| 2008 FY | 156.25 Million SEK | 20.5% |
| 2007 FY | 129.66 Million SEK | 11.28% |
| 2006 FY | 116.52 Million SEK | 40.51% |
| 2005 FY | 82.92 Million SEK | 11.5% |
| 2004 FY | 74.37 Million SEK | 20.66% |
| 2003 FY | 61.63 Million SEK | 24.87% |
| 2002 FY | 49.36 Million SEK | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Heart Tronics, Inc. | - USD | -Infinity% |
| Lombard Medical, Inc. | 955 Thousand USD | -207020.419% |
| Hamilton Thorne Ltd. | 35.08 Million USD | -5537.994% |
| Wellstar International, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -307.354% |
| QHSLab, Inc. | 793.6 Thousand USD | -249141.753% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 261484.705% |
| BrainsWay Ltd. | 23.09 Million USD | -8466.108% |
| Electromedical Technologies, Inc. | 1.04 Million USD | -189090.869% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| Theraclion SA | -1.08 Million USD | 183182.882% |
| Avitar, Inc. | 836.7 Thousand USD | -236304.359% |
| AVITA Medical, Inc. | 41.68 Million USD | -4644.841% |
| Aurora Spine Corporation | 8.21 Million USD | -23988.779% |
| SS Innovations International, Inc. | 713.44 Thousand USD | -277145.542% |
| Nanomix Corporation | -69.45 Thousand USD | 2847864.116% |
| CVR Medical Corp. | - USD | -Infinity% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Össur hf. | 485.57 Million USD | -307.354% |
| BioElectronics Corporation | 466.38 Thousand USD | -424010.397% |
| ECGI Holdings, Inc. | - USD | -Infinity% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 1012791.928% |
| Stratec SE | 71.58 Million USD | -2663.008% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | -11713.028% |
| Escalon Medical Corp. | 5.14 Million USD | -38336.187% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | -736371.342% |
| Odyssey Group International, Inc. | - USD | -Infinity% |
| Guided Therapeutics, Inc. | 36 Thousand USD | -5494344.444% |
| Polarean Imaging plc | 335.48 Thousand USD | -589497.685% |
| NewCardio, Inc. | 105.1 Thousand USD | -1881863.407% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | -180696.62% |
| Vivos Inc. | -6036.00 USD | 32770146.388% |
| Kelyniam Global, Inc. | 2.03 Million USD | -97047.555% |
| MicroPort Scientific Corporation | 532.09 Million USD | -271.736% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | -3494970.149% |
| VMS Rehab Systems, Inc. | -10.44 USD | 18946360253.257% |
| Medical Supply International USA, Inc. | 1.75 Million USD | -112370.845% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | -336552.2% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 197800100.0% |
| Positron Corporation | -353.46 Thousand USD | 559702.79% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| ALR Technologies Inc. | 4945.00 USD | -39999900.0% |
| Vycor Medical, Inc. | 1.31 Million USD | -150243.479% |
| SANUWAVE Health, Inc. | 14.36 Million USD | -13671.496% |
| IR-Med Inc. | -17 Thousand USD | 11635394.118% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | -958145.123% |
| United American Healthcare Corporation | -8000.00 USD | 24725100.0% |
| Capital Group Holdings, Inc. | - USD | -Infinity% |
| Urologix, Inc. | 6.09 Million USD | -32363.483% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 15333433.333% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 624683.585% |
| Qualis Innovations, Inc. | - USD | -Infinity% |
| Smith & Nephew plc | 3.91 Billion USD | 49.425% |
| NIOX Group Plc | 28.13 Million USD | -6930.814% |
| Fuse Medical, Inc. | 10.73 Million USD | -18327.705% |
| Broncus Holding Corporation | 7.22 Million USD | -27269.586% |
| Brain Scientific Inc. | 54.32 Thousand USD | -3640949.241% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | -247285.444% |
| Health Logic Interactive Inc. | - USD | -Infinity% |